國立虎尾科技大學 |

Early-stage Lung Cancer = Screening and Management /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Early-stage Lung Cancer/ edited by Xiangpeng Zheng, Ming Li, Guozhen Zhang.
其他題名:	Screening and Management /
其他作者:	Zheng, Xiangpeng.
面頁冊數:	XXIV, 423 p. 181 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Respiratory organs—Diseases. -
電子資源:	https://doi.org/10.1007/978-981-10-7596-4
ISBN:	9789811075964

Early-stage Lung Cancer = Screening and Management /
Early-stage Lung CancerScreening and Management /[electronic resource] :edited by Xiangpeng Zheng, Ming Li, Guozhen Zhang. - 1st ed. 2018. - XXIV, 423 p. 181 illus. in color.online resource.

The pathological advances of early lung adenocarcinoma -- Advancement in Cross-sectional Anatomy of the Lung -- Low-dose CT Screening of Lung Cancer -- The Advances of PET/CT clinical application in micronodular lung cancer -- Angiogenesis-dependent tumor progression -- Pure Ground-glass Nodules -- Part-solid Ground-glass Nodules -- Solid Pulmonary Nodules -- CT-based Categorization of Small Pulmonary Adenocarcinoma and Differential Diagnosis -- Multiple Primary Lung Cancer -- Management Strategies of Micronodular Lung Cancer: Surgical Perspectives -- Management Strategies of Early-stageLung Cancer: Stereotactic Ablative Radiation Therapy -- Radiofrequency ablation -- Case Discussion.

This book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for CT imaging. Part II focuses on the imaging features, differential diagnosis and radiologic-pathologic correlations of ESLCs in the categories pGGN, mGGN and solid nodules in compliance with the Guidelines on Lung Cancer Screening from the National Comprehensive Cancer Network (NCCN). Part III briefly introduces therapeutic management strategies for ESLCs, including surgical and non-surgical approaches, for instance stereotactic ablative radiation therapy (SABR) and radiofrequency ablation (RFA). Lastly, the authors have meticulously prepared 50 clinical cases of pathologically proven benign and malignant pulmonary nodules with in-depth discussion and experts’ comments to further readers’ understanding of practical imaging and management strategies of ESLCs.

ISBN: 9789811075964

Standard No.: 10.1007/978-981-10-7596-4doiSubjects--Topical Terms:

1254083
Respiratory organs—Diseases.

LC Class. No.: RC705-779

Dewey Class. No.: 616.2

Early-stage Lung Cancer = Screening and Management /
LDR:03158nam a22003975i 4500 001 997695
003 DE-He213
005 20200629152751.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811075964 $9 978-981-10-7596-4
024 7 $a 10.1007/978-981-10-7596-4 $2 doi
035 $a 978-981-10-7596-4
050 4 $a RC705-779
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
072 7 $a MJL $2 thema
082 0 4 $a 616.2 $2 23
245 1 0 $a Early-stage Lung Cancer $h [electronic resource] : $b Screening and Management / $c edited by Xiangpeng Zheng, Ming Li, Guozhen Zhang.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a XXIV, 423 p. 181 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a The pathological advances of early lung adenocarcinoma -- Advancement in Cross-sectional Anatomy of the Lung -- Low-dose CT Screening of Lung Cancer -- The Advances of PET/CT clinical application in micronodular lung cancer -- Angiogenesis-dependent tumor progression -- Pure Ground-glass Nodules -- Part-solid Ground-glass Nodules -- Solid Pulmonary Nodules -- CT-based Categorization of Small Pulmonary Adenocarcinoma and Differential Diagnosis -- Multiple Primary Lung Cancer -- Management Strategies of Micronodular Lung Cancer: Surgical Perspectives -- Management Strategies of Early-stageLung Cancer: Stereotactic Ablative Radiation Therapy -- Radiofrequency ablation -- Case Discussion.
520 $a This book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for CT imaging. Part II focuses on the imaging features, differential diagnosis and radiologic-pathologic correlations of ESLCs in the categories pGGN, mGGN and solid nodules in compliance with the Guidelines on Lung Cancer Screening from the National Comprehensive Cancer Network (NCCN). Part III briefly introduces therapeutic management strategies for ESLCs, including surgical and non-surgical approaches, for instance stereotactic ablative radiation therapy (SABR) and radiofrequency ablation (RFA). Lastly, the authors have meticulously prepared 50 clinical cases of pathologically proven benign and malignant pulmonary nodules with in-depth discussion and experts’ comments to further readers’ understanding of practical imaging and management strategies of ESLCs.
650 0 $a Respiratory organs—Diseases. $3 1254083
650 0 $a Radiology. $3 673943
650 0 $a Oncology . $3 1253469
650 1 4 $a Pneumology/Respiratory System. $3 668561
650 2 4 $a Diagnostic Radiology. $3 593950
650 2 4 $a Oncology. $3 593951
700 1 $a Zheng, Xiangpeng. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1289079
700 1 $a Li, Ming. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 898736
700 1 $a Zhang, Guozhen. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1289080
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811075957
776 0 8 $i Printed edition: $z 9789811075971
776 0 8 $i Printed edition: $z 9789811356568
856 4 0 $u https://doi.org/10.1007/978-981-10-7596-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)